Seattle doctors developed a blood test that determines the parental origin of the RB1 mutation in retinoblastoma.
Following her shock cancer diagnosis last year, the Princess of Wales took a step back from royal duties to focus on her recovery and spent the summer with her family in Windsor, away from the public ...
Cancer accounted for nearly 10 million deaths in 2020—almost one in every six deaths globally—according to the World Health Organization. Because the detection of abnormal diseased cellular growth ...
The FDA expanded the approval of trastuzumab deruxtecan for treatment of breast cancer.The new indication applies to use of ...
Recent trends reveal a sharp rise in cancer cases in India, with younger patients and a lack of effective screening programs ...
Kate Middleton’s serene retreat during her cancer treatment, Bucklebury Manor, has become a point of fascination for royal ...
The approval is based on findings from a phase 3 study which demonstrated the drug’s superiority over chemotherapy.
From pain management to hormone therapy, here are a few ways to address reproductive and sexual issues after cervical cancer ...
A Peter Mac-led international clinical trial has shown adding an immunotherapy drug to the chemotherapy that patients receive ...
Just 11 days after AstraZeneca and Daiichi Sankyo gained FDA approval | The FDA has cleared AstraZeneca and Daiichi Sankyo's ...
The dancer is currently living life to the full as she reunited with her Strictly Come Dancing co-stars after an injury ...
Shares of Leap Therapeutics slid after disappointing initial data from two mid-stage clinical trials of its oncology treatment, resulting in the discontinuation of one clinical program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback